SEPN · Categories · Form 4
SEPN - SEC Form 4 insider transactions
Septerna Inc. (SEPN) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for SEPN
- SEC Form 4 filed by Bhatt Elizabeth4 - Septerna, Inc. (0001984086) (Issuer)
- Chief People Officer Shaikhly Samira exercised 70,453 shares at a strike of $1.84 and sold $1,979,838 worth of shares (70,453 units at $28.10) (SEC Form 4)4 - Septerna, Inc. (0001984086) (Issuer)
- President and COO Bhatt Elizabeth exercised 4,000 shares at a strike of $6.81 and sold $115,860 worth of shares (4,000 units at $28.97) (SEC Form 4)4 - Septerna, Inc. (0001984086) (Issuer)
- SEC Form 4 filed by SVP, Drug Discovery Long Daniel D.4 - Septerna, Inc. (0001984086) (Issuer)
- SEC Form 4 filed by SVP, Biological Sciences Klein Uwe4 - Septerna, Inc. (0001984086) (Issuer)
- SEC Form 4 filed by Chief People Officer Shaikhly Samira4 - Septerna, Inc. (0001984086) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Labrucherie Gil M4 - Septerna, Inc. (0001984086) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Kim Jae B.4 - Septerna, Inc. (0001984086) (Issuer)
- SEC Form 4 filed by President and COO Bhatt Elizabeth4 - Septerna, Inc. (0001984086) (Issuer)
- SEC Form 4 filed by Chief Executive Officer Finer Jeffrey4 - Septerna, Inc. (0001984086) (Issuer)
- SEC Form 4 filed by Chief Legal Officer Wilson Mark Andrew4 - Septerna, Inc. (0001984086) (Issuer)
- SVP, Drug Discovery Long Daniel D. sold $63,223 worth of shares (3,501 units at $18.06), decreasing direct ownership by 4% to 92,911 units (SEC Form 4)4 - Septerna, Inc. (0001984086) (Issuer)
- SEC Form 4 filed by Director Gottesdiener Keith Michael4 - Septerna, Inc. (0001984086) (Issuer)
- SVP, Biological Sciences Klein Uwe exercised 23,008 shares at a strike of $4.10 (SEC Form 4)4 - Septerna, Inc. (0001984086) (Issuer)
- SEC Form 4 filed by Chief People Officer Shaikhly Samira4 - Septerna, Inc. (0001984086) (Issuer)
- SEC Form 4 filed by President and COO Bhatt Elizabeth4 - Septerna, Inc. (0001984086) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Kim Jae B.4 - Septerna, Inc. (0001984086) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Labrucherie Gil M4 - Septerna, Inc. (0001984086) (Issuer)
- SEC Form 4 filed by Chief Executive Officer Finer Jeffrey4 - Septerna, Inc. (0001984086) (Issuer)
- SEC Form 4 filed by SVP, Drug Discovery Long Daniel D.4 - Septerna, Inc. (0001984086) (Issuer)
- SEC Form 4 filed by SVP, Biological Sciences Klein Uwe4 - Septerna, Inc. (0001984086) (Issuer)
- SEC Form 4 filed by Director Ra Capital Management, L.P.4 - Septerna, Inc. (0001984086) (Issuer)
- SEC Form 4 filed by Director Sharp Shalini4 - Septerna, Inc. (0001984086) (Issuer)
- SEC Form 4 filed by Director Tong Jeffrey K4 - Septerna, Inc. (0001984086) (Issuer)
- SEC Form 4 filed by Director Coulie Bernard4 - Septerna, Inc. (0001984086) (Issuer)
- SEC Form 4 filed by Director Simson Jake4 - Septerna, Inc. (0001984086) (Issuer)
- SEC Form 4 filed by Director Bassan Abraham4 - Septerna, Inc. (0001984086) (Issuer)
- SEC Form 4 filed by Director Ezekowitz Alan4 - Septerna, Inc. (0001984086) (Issuer)
- CEO and President Finer Jeffrey exercised 55,000 shares at a strike of $2.76, increasing direct ownership by 7% to 826,907 units (SEC Form 4)4 - Septerna, Inc. (0001984086) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Labrucherie Gil M4 - Septerna, Inc. (0001984086) (Issuer)